Sneek Peak: Rick Stewart on Cytisinicline redefining the future of nicotine dependence

What if a naturally derived compound used for decades overseas could finally transform smoking cessation in the U.S.?Rick Stewart, CEO of Achieve Life Sciences, just received FDA acceptance for cytisinicline's NDA—a major milestone that could help millions quit smoking.🎙️ Full episode drops December 4In the complete interview, we dive into:• FDA NDA acceptance and what comes next• Commercial readiness and go-to-market strategy• Financial strategy and capital efficiency• Public health impact at scaleSubscribe so you don't miss it.#SneakPeek #SmokingCessation #PublicHealth #FDA